Diabetes and Ramadan

Module 4: Managing diabetes during Ramadan

Please log in to access the chapters in this module.
CME Credits: 1
Module duration: 1 hour
Launch date: Winter 2018 (version 1)
Updated: Spring 2022 (version 2)
Expiry date: March 2027
Audience: Diabetes and Metabolism Specialists (Subspeciality), Endocrinologists (Subspeciality), General Physicians (Subspeciality), Public Health Physicians (Basic)

In this module, Module 4, we are going to discuss possible medications during Ramadan fasting. The medications are either for type 1 or type 2. For type 1 - insulin - exploring different studies done on insulin treatment during Ramadan for type 1. And, for type 2, we're going to discuss also some trials done to check the safety and efficacy of oral hypoglycaemic medication and non-insulin treatment like GLP-1 receptor agonist, an oral medication, metformin, sulphonylurea, SGLT-2 inhibitors, DPP-4 inhibitors, insulin sensitisers. All these medications, some of them are having randomised control trials during Ramadan and some are not. So we will try to screen the research done on Ramadan fasting, to get how to deal with medication during Ramadan by the end of the module.

In this module, you will learn about how to adjust diabetes regimens in patients with type 1 diabetes who wish to fast as well as consider the clinical trials that have been conducted in those with type 2 diabetes during Ramadan. This will allow you to develop your skills on managing people with diabetes during their fast.

A number of clinical guidelines for people with diabetes who choose to fast have been published. However, these recommendations are based on expert consensus and healthcare professionals may feel apprehensive when applying the recommendations to individual diabetes management plans and/or treatment pathways.

A range of clinical trials for both type 1 and type 2 diabetes and possible treatment options are discussed to help provide clear guidance on how research outcomes can be applied to clinical practice. Knowledge checks will help you develop confidence when making decisions about which regimens to recommend to patients who wish to fast during Ramadan.

Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A, Nakhi AB, Tayeb K, Thomas A. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010 Aug;33(8):1895-902.
http://www.ncbi.nlm.nih.gov/pubmed/20668157

Velayudhan M. Managing diabetes during the Muslim fasting month of Ramadan. Med J Malaysia. 2012 Jun;67(3):353-4
https://www.ncbi.nlm.nih.gov/pubmed/23082439

Hui E, Bravis V, Hassanein M, Hanif W, Malik R, Chowdhury TA, Suliman M, Devendra D. Management of people with diabetes wanting to fast during Ramadan. BMJ. 2010 Jun 22;340:c3053.
https://www.ncbi.nlm.nih.gov/pubmed/20570867

Hui E, Devendra D. Diabetes and fasting during Ramadan Diabetes Metab Res Rev 2010 Nov;26(8):606-10
https://www.ncbi.nlm.nih.gov/pubmed/20939000

Learning Outcomes

By the end of this module, you will be able to:

Explain the evidence from clinical trials investigating the effects of fasting during Ramadan in patients with type 1 diabetes and optimisation of insulin regimens

Interpret the evidence from clinical trials investigating the effects of fasting during Ramadan on type 2 diabetes and a range of oral antidiabetic drugs

Plan your approach to a consultation with typical patients with type 1 and type 2 diabetes wishing to fast during Ramadan


This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.


Contributors

Professor
Inass Shaltout
Author
Professor
Wasim Hanif
Expert Reviewer
Assessment Setter
Assessment Setter